Form D · Other Health Care
GENOMIC LIFE, INC.
La Jolla, CA · CIK 0001845015
Offering snapshot reported May 8, 2024 · SEC filing
- Reported sold
- $10M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 6, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2024 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-512708
Source: Form D, filed May 8, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Cole | Director, Executive |
| Kim Popovits | Director |
| Randal Scott | Director, Executive |
| A. Greig Woodring | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3344 Torrey Pines Court
La Jolla, CA, 92037
La Jolla, CA, 92037